937 related articles for article (PubMed ID: 30884365)
1. Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An
Joling M; Vriend C; Raijmakers PGHM; van der Zande JJ; Lemstra AW; Berendse HW; Booij J; van den Heuvel OA
Neuroimage Clin; 2019; 22():101755. PubMed ID: 30884365
[TBL] [Abstract][Full Text] [Related]
2. Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An
van der Zande JJ; Joling M; Happach IG; Vriend C; Scheltens P; Booij J; Lemstra AW
Neuroimage Clin; 2020; 25():102062. PubMed ID: 31790878
[TBL] [Abstract][Full Text] [Related]
3. Lower
Joling M; Vriend C; van der Zande JJ; Lemstra AW; van den Heuvel OA; Booij J; Berendse HW
Neuroimage Clin; 2018; 19():130-136. PubMed ID: 30035010
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Extrastriatal
Joling M; Vriend C; van den Heuvel OA; Raijmakers PGHM; Jones PA; Berendse HW; Booij J
J Nucl Med; 2017 Jul; 58(7):1117-1123. PubMed ID: 27856628
[No Abstract] [Full Text] [Related]
5. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
[TBL] [Abstract][Full Text] [Related]
6. Extrastriatal
Nicastro N; Fleury V; Broc N; Burkhard PR; Garibotto V
Parkinsonism Relat Disord; 2020 Sep; 78():38-43. PubMed ID: 32698058
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
8. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
[TBL] [Abstract][Full Text] [Related]
9. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
10. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter binding and anxiety symptoms in Parkinson's disease.
Joling M; van den Heuvel OA; Berendse HW; Booij J; Vriend C
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):89-94. PubMed ID: 28899958
[TBL] [Abstract][Full Text] [Related]
12. Preserved Extrastriatal
Nicastro N; Burkhard PR; Garibotto V
Mol Imaging Biol; 2020 Dec; 22(6):1592-1599. PubMed ID: 32468408
[TBL] [Abstract][Full Text] [Related]
13. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
14. Processing speed is related to striatal dopamine transporter availability in Parkinson's disease.
Vriend C; van Balkom TD; van Druningen C; Klein M; van der Werf YD; Berendse HW; van den Heuvel OA
Neuroimage Clin; 2020; 26():102257. PubMed ID: 32344372
[TBL] [Abstract][Full Text] [Related]
15. Extrastriatal
Nicastro N; Garibotto V; Burkhard PR
BMC Neurol; 2020 May; 20(1):192. PubMed ID: 32416724
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
[TBL] [Abstract][Full Text] [Related]
17. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
18. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
19. Test-retest reproducibility of extrastriatal binding with
Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
[No Abstract] [Full Text] [Related]
20. Cholinesterase inhibitor use does not significantly influence the ability of 123I-FP-CIT imaging to distinguish Alzheimer's disease from dementia with Lewy bodies.
Taylor JP; Colloby SJ; McKeith IG; Burn DJ; Williams D; Patterson J; O'Brien JT
J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1069-71. PubMed ID: 17299017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
